American Innovation

Predictions about quantum technology are often fraught with hype and exaggeration. Nonetheless, emerging quantum technologies will bring to market significant new capabilities as well as economic and strategic opportunities—and these will require supportive policy attention.

TRIPS waivers undermine the U.S. pharmaceutical industry by degrading the IP protections which are essential to the pharmaceutical innovation ecosystem. Less innovation in the pharmaceutical industry means fewer vaccines and drugs in the future, leaving the United States and other nations less prepared for future pandemics and other health emergencies.

Richard Elkus Jr. reminds us of how the United States lost track of its strategic perspective, and what it must do to reestablish its competitive and strategic position amongst nations.

Commerce's guidance on requiring semiconductor companies seeking CHIPS funding to provide workers access to child care is a pragmatic move, clearly aligned with the nation’s security interests.

Geopolitical lines are being redrawn, and this time, India is partnering with the United States to realize its vast potential as an innovation-driven twenty-first century economy.